Acyclovir

Product NDC: 71335-1284
11-digit product format: 713351284
Labeler code: 71335
Product ID: 71335-1284_ea778f5c-6b11-4245-9ca4-3fd8c4e0c962
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA210401
Marketing category: ANDA
Marketing start: 2018-05-04
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 400 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71335-1284-1	71335128401	35 TABLET in 1 BOTTLE (71335-1284-1)	35 tablet	2018-05-04	0000-00-00	No	No	Current
71335-1284-2	71335128402	90 TABLET in 1 BOTTLE (71335-1284-2)	90 tablet	2019-12-06	0000-00-00	No	No	Current